Galmed Pharmaceuticals Ltd. (GLMD) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.59
-5.80%
Mkt Cap $3.37M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $1.30M | — | — | -$0.38 | -$0.92 | -142.11% | — | — |
| Q4 2025 Nov 26, 2025 | $1.37M | — | — | -$0.54 | -$0.33 | +38.89% | — | — |
| Q3 2025 Aug 28, 2025 | $1.45M | — | — | -$0.83 | $0.63 | +175.90% | — | — |
| Q2 2025 May 22, 2025 | $1.54M | $1.54M | +0.00% | -$0.89 | -$0.62 | +30.34% | — | — |
| Q2 2025 Apr 2, 2025 | — | $1.64M | — | — | -$11.76 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$2.31 | — | — | — |
| Q3 2024 Aug 28, 2024 | — | — | — | — | $2.16 | — | — | — |
| Q2 2024 May 30, 2024 | — | — | — | — | -$2.76 | — | — | — |
| Q2 2024 Apr 4, 2024 | — | — | — | -$0.32 | -$11.76 | -3575.00% | — | — |
| Q4 2023 Nov 22, 2023 | — | — | — | -$0.27 | -$2.88 | -966.67% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.34 | -$11.40 | -3252.94% | — | — |
| Q2 2023 Jun 1, 2023 | — | — | — | -$1.50 | -$13.09 | -772.67% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | -$0.14 | -$18.00 | -12757.14% | — | — |
| Q4 2022 Nov 16, 2022 | — | — | — | -$27.00 | -$37.80 | -40.00% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$41.40 | -$27.00 | +34.78% | — | — |
| Q2 2022 May 17, 2022 | — | — | — | -$59.39 | -$43.20 | +27.26% | — | — |
| Q2 2022 May 2, 2022 | — | — | — | — | -$4.45 | — | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$71.99 | -$55.79 | +22.50% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$73.79 | -$59.39 | +19.51% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$79.19 | -$68.39 | +13.64% | — | — |
| Q1 2021 Mar 18, 2021 | — | — | — | -$71.99 | -$86.39 | -20.00% | — | — |
| Q4 2020 Nov 12, 2020 | — | — | — | -$57.59 | -$57.59 | +0.00% | — | — |
| Q3 2020 Aug 6, 2020 | — | — | — | -$55.79 | -$46.80 | +16.11% | — | — |
| Q2 2020 May 14, 2020 | — | — | — | -$66.59 | -$52.19 | +21.62% | — | — |
| Q1 2020 Mar 12, 2020 | — | — | — | -$66.59 | -$70.19 | -5.41% | — | — |
| Q4 2019 Nov 6, 2019 | — | — | — | -$57.59 | -$37.80 | +34.36% | — | — |
| Q3 2019 Aug 5, 2019 | — | — | — | -$43.20 | -$36.00 | +16.67% | — | — |
| Q2 2019 May 7, 2019 | — | — | — | -$34.20 | -$30.60 | +10.53% | — | — |
| Q1 2019 Mar 13, 2019 | — | — | — | -$21.60 | -$34.20 | -58.33% | — | — |
| Q4 2018 Nov 5, 2018 | $4.20M | $1.50M | -64.29% | -$25.20 | -$9.00 | +64.29% | — | — |
| Q3 2018 Aug 2, 2018 | $253.13K | $270.00K | +6.67% | -$28.80 | -$30.60 | -6.25% | — | — |
| Q2 2018 May 9, 2018 | $346.17K | $268.00K | -22.58% | -$41.40 | -$30.60 | +26.09% | — | — |
| Q1 2018 Mar 13, 2018 | — | $274.00K | — | -$41.40 | -$48.60 | -17.39% | — | — |
| Q4 2017 Nov 9, 2017 | $294.84K | $273.00K | -7.41% | -$48.60 | -$41.40 | +14.81% | — | — |
| Q3 2017 Jul 31, 2017 | $320.00K | $270.00K | -15.63% | -$59.39 | -$39.60 | +33.32% | — | — |
| Q2 2017 May 15, 2017 | $352.63K | $268.00K | -24.00% | -$70.19 | -$46.80 | +33.32% | — | — |
| Q1 2017 Mar 23, 2017 | — | $274.00K | — | -$0.30 | -$71.99 | -23896.67% | — | — |
| Q4 2016 Nov 7, 2016 | $217.74K | $193.00K | -11.36% | -$66.59 | -$59.39 | +10.81% | — | — |
| Q3 2016 Aug 3, 2016 | — | — | — | -$64.79 | -$70.19 | -8.33% | — | — |
| Q2 2016 May 16, 2016 | — | — | — | -$61.19 | -$59.39 | +2.94% | — | — |
| Q4 2015 Dec 31, 2015 | — | — | — | — | -$4.33 | — | — | — |
| Q4 2015 Nov 9, 2015 | — | — | — | -$45.00 | -$37.80 | +16.00% | — | — |
| Q3 2015 Aug 13, 2015 | — | — | — | -$50.39 | -$37.80 | +24.99% | — | — |
| Q2 2015 May 13, 2015 | — | — | — | -$46.80 | -$39.60 | +15.38% | — | — |
| Q1 2015 Mar 31, 2015 | — | — | — | — | -$3.33 | — | — | — |
| Q4 2014 Nov 12, 2014 | — | — | — | -$0.37 | -$0.31 | +16.22% | — | — |
| Q3 2014 Jul 25, 2014 | — | — | — | -$0.35 | -$27.00 | -7614.29% | — | — |
| Q2 2014 May 14, 2014 | — | — | — | -$0.29 | -$0.27 | +6.90% | — | — |
| Q4 2013 Dec 31, 2013 | — | — | — | — | -$21.45 | — | — | — |
| Q3 2013 Sep 30, 2013 | — | — | — | — | -$1.96 | — | — | — |
| Q2 2013 Jun 30, 2013 | — | — | — | — | -$2.82 | — | — | — |
| Q1 2013 Mar 31, 2013 | — | — | — | — | -$1.80 | — | — | — |
| Q4 2012 Dec 31, 2012 | — | — | — | — | -$0.00 | — | — | — |